Close Menu


While longitudinal studies in proteomics are still uncommon, Skates said that such research calls for clinical assays that need to be especially precise.

The agreement will give the company's customers access to HMS-developed information to support genetic counseling after testing.

Using a morphological classifier and computational method for integrating this data with information from an RNA interference screen, a group of researchers from the Massachusetts Institute of Technology and Harvard University delved into genetic interactions affecting the Rho signaling pathway in Drosophila.

The research provides some short-term consumables revenue for Wafergen and validates its SmartChip real-time PCR system in advance of its full commercial launch, a company executive said.

Scientists published a paper online in Science today describing their composite of multiple signals method for narrowing in on positive selection signals in the human genome.

The university has paused construction of its $1 billion Allston Science Complex due to the "altered financial landscape."

The $1.4 million grant will support a collaboration to develop sub-cellular tracking and imaging software tools.

Originally developed in the lab of Phillip Sharp at the Massachusetts Institute of Technology, miRNA sponges are transcripts expressed from strong promoters that contain multiple tandem binding sites to an miRNA of interest.

CEO Patrick Kleyn said this week that the Cambridge, Mass.-based startup is looking to partner with pharmaceutical and biotechnology companies that would like to use the firm's small-molecule microarrays, or SMMs, in their drug-discovery programs.

A consortium of Harvard-affiliated researchers will use the LNA Knockdown Library technology at the ICCB-Longwood Facility.


A new analysis suggests warming, not the arrival of humans, led to the extinction of the woolly rhinoceros thousands of years ago, the Economist reports.

Chinese health officials uncovered SARS-CoV-2 viral RNA on imported frozen food, but the New York Times reports catching COVID-19 that way would be unlikely.

The UK has ordered 60 million coronavirus vaccine doses from Novavax and 30 million doses from Janssen, according to the Guardian.

In Science this week: machine learning model predicts whether ion channel mutations will cause disease, and more.